Summer Infant, Inc. (SUMR) Misses Q2 EPS by 10c, Revenues Fall Inline
Tweet
Share
E-mailGet Alerts SUMR Hot Sheet
Price: $11.99 --0%
Financial Fact:
Net operating income: 997K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Net operating income: 997K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Summer Infant, Inc. (NASDAQ: SUMR) reported Q2 EPS of $0.05, $0.10 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $61 million versus the consensus estimate of $60.16 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- MDxHealth SA (MDXH) Misses Q2 EPS by 1c ; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
